This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
peer-reviewed publication
trusted source
proofread
Ingestible microbiome sampling pill technology advances toward human clinical trials
Significant progress has been made at Tufts University School of Engineering in the development of a small device, about the size of a vitamin pill, that can be swallowed and passed through the gastrointestinal tract to sample the full inventory of microorganisms in an individual's gastro-intestinal tract.
This device has the potential to advance research on the relationship between resident bacteria and a wide range of health conditions. It could also serve as a diagnostic tool for adjusting the microbiome or administering drugs to treat those conditions.
The device has completed preclinical characterization—as presented in the journal Device—paving the way for upcoming human clinical trials. It is characterized by a 3D printed soft elastic exterior with sidewall inlets that open in response to the changing acidity as the pill reaches the small intestine.
The pill uses elastic microvalves with swellable polyacrylate beads that close the inlets once intestinal content has been collected. The technology was developed at Tufts Nano Lab by a team led by Professor Sameer Sonkusale, along with post-doctoral researcher Ruben Del-Rio-Ruiz who is lead author on the preclinical study.
A second team of researchers led by Professor Giovanni Widmer at the Cummings School of Veterinary Medicine at Tufts University assisted by Ph.D. candidate Debora Silva, performed the tests in animals and analyzed the samples collected by the pill.
Improvements over previous versions of the pill include using a soft elastic exterior rather than a rigid shell, to make it easier to ingest, and significantly improved control over localized sampling of the microbiome in the small intestine.
Current techniques to study the intestinal microbiome primarily rely on fecal matter. This technology represents a significant advance in understanding the function of the thousands of microbial species populating the entire length of the gastrointestinal tract and their effects on health.
More information: Soft Autonomous Ingestible Device for Sampling the Small Intestinal Microbiome, Device (2024). DOI: 10.1016/j.device.2024.100406. www.cell.com/device/fulltext/S2666-9986(24)00242-4
